- $2.49bn
- $6.71bn
- $2.56bn
- 65
- 86
- 42
- 69
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 5.54 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.49 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 7.66 | ||
| Price to Sales | 0.98 | ||
| EV to EBITDA | 14.72 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.74% | ||
| Return on Equity | -13.72% | ||
| Operating Margin | -10.78% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,254.05 | 1,876.89 | 2,659.8 | 2,628.8 | 2,556.7 | 2,339.85 | 2,345.91 | 21.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +8.81 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company provides research and analytics, content aggregation, and workflow software solutions. Within the IP segment, the Company provides IP Maintenance, IP Intelligence, and IP Management solutions. Within the LS&H segment, the Company provides research and development, regulatory and safety, and commercialization solutions. It is also a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. It is also engaged in providing comprehensive and integrated solutions to support patent preparation, filing and prosecution, offering patent practitioners with automation and artificial intelligence (AI)-enabled solutions.
Directors
- Jerre Stead CHM (78)
- Andrew Snyder VCH (51)
- Jonathan Collins CFO (41)
- Mukhtar Ahmed CEX (53)
- Gordon Samson CEX
- Julie Wilson CHO (56)
- Jaspal Chahal GCN
- Steen Lomholt-thomsen OTH
- Anthony Munk LED (60)
- Michael Angelakis DRC (57)
- Usama Cortas IND (43)
- Kosty Gilis IND (47)
- Balakrishnan Iyer IND (64)
- Nicholas Macksey IND (41)
- Charles Neral IND (62)
- Jane Okun Bomba IND (58)
- Richard Roedel IND (72)
- Sheryl von Blucher IND (59)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 7th, 2019
- Public Since
- October 29th, 2018
- No. of Shareholders
- 91
- No. of Employees
- 12,000
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
New York Stock Exchange- Shares in Issue
- 688,956,113
- Address
- 70 St. Mary Axe, LONDON, EC3A 8BE
- Web
- https://clarivate.com/
- Phone
- +44 2074334000
- Contact
- Mark Donohue
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for CLVT
Q1 2025 Clarivate PLC Earnings Call
Clarivate PLC Annual Shareholders Meeting
CLARIVATE PLC Annual Shareholders Meeting
Q2 2025 Clarivate PLC Earnings Release
Similar to CLVT
ABM Industries
New York Stock Exchange
ACCO Brands
New York Stock Exchange
Aris Water Solutions
New York Stock Exchange
BGSF
New York Stock Exchange
Block
New York Stock Exchange
FAQ
What is the CLARIVATE share price?
As of Today at 07:58 UTC, shares in CLARIVATE are trading at $3.62. This share price information is delayed by 15 minutes.
How has the CLARIVATE share price performed this year?
Shares in CLARIVATE last closed at $3.62 and the price had moved by -48.29% over the past 365 days. In terms of relative price strength the CLARIVATE share price has underperformed the S&P500 Index by -52.27% over the past year.
What are the analyst and broker recommendations for CLARIVATE?
The overall consensus recommendation for CLARIVATE is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the CLARIVATE dividend yield?
CLARIVATE does not currently pay a dividend.
Does CLARIVATE pay a dividend?
CLARIVATE does not currently pay a dividend.
When does CLARIVATE next pay dividends?
CLARIVATE does not currently pay a dividend.
How do I buy CLARIVATE shares?
To buy shares in CLARIVATE you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CLARIVATE?
As of the previous close price of $3.62, shares in CLARIVATE had a market capitalisation of $2.49bn.
Where are CLARIVATE shares listed?
Here are the trading details for CLARIVATE:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CLVT
What kind of share is CLARIVATE?
Based on an overall assessment of its quality, value and momentum CLARIVATE is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CLARIVATE share price forecast for 2025?
The analyst consensus target price for shares in CLARIVATE is $5.41. That is 49.45% above the last closing price of $3.62.
Analysts covering CLARIVATE currently have a consensus Earnings Per Share (EPS) forecast of $0.64 for the next financial year.
Find out moreWhat is the trend in the CLARIVATE share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CLARIVATE. Over the past six months, its share price has underperformed the S&P500 Index by -40.66%.
As of the last closing price of $3.62, shares in CLARIVATE were trading -33.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CLARIVATE PE Ratio?
The CLARIVATE PE ratio based on its reported earnings over the past 12 months is 5.54. The shares last closed at $3.62.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CLARIVATE?
CLARIVATE's management team is headed by:
- Jerre Stead - CHM
- Andrew Snyder - VCH
- Jonathan Collins - CFO
- Mukhtar Ahmed - CEX
- Gordon Samson - CEX
- Julie Wilson - CHO
- Jaspal Chahal - GCN
- Steen Lomholt-thomsen - OTH
- Anthony Munk - LED
- Michael Angelakis - DRC
- Usama Cortas - IND
- Kosty Gilis - IND
- Balakrishnan Iyer - IND
- Nicholas Macksey - IND
- Charles Neral - IND
- Jane Okun Bomba - IND
- Richard Roedel - IND
- Sheryl von Blucher - IND